These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 7053599)
1. Comparison of the electrophysiologic effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardia. Klein GJ; Gulamhusein S; Prystowsky EN; Carruthers SG; Donner AP; Ko PT Am J Cardiol; 1982 Jan; 49(1):117-24. PubMed ID: 7053599 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia. Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627 [TBL] [Abstract][Full Text] [Related]
3. Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia. Belhassen B; Glick A; Laniado S Circulation; 1988 Apr; 77(4):795-805. PubMed ID: 3349581 [TBL] [Abstract][Full Text] [Related]
4. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia. Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia. Manz M; Steinbeck G; Lüderitz B Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693 [TBL] [Abstract][Full Text] [Related]
6. Effects of oral verapamil in patients with atrioventricular reentrant tachycardia incorporating an accessory pathway. Wu D; Kou HC; Yeh SJ; Lin FC; Hung JS Circulation; 1983 Feb; 67(2):426-33. PubMed ID: 6848233 [TBL] [Abstract][Full Text] [Related]
7. Combined verapamil and propranolol for supraventricular tachycardia. Yee R; Gulamhusein SS; Klein GJ Am J Cardiol; 1984 Mar; 53(6):757-63. PubMed ID: 6702624 [TBL] [Abstract][Full Text] [Related]
8. Atrioventricular node reentry: intravenous verapamil as a method of defining multiple electrophysiologic types. Hamer A; Peter T; Mandel W Am Heart J; 1983 Apr; 105(4):629-42. PubMed ID: 6837417 [TBL] [Abstract][Full Text] [Related]
9. Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents. Gomes JA; Hariman RJ; Kang PS; Chowdry IH J Am Coll Cardiol; 1985 Jan; 5(1):45-57. PubMed ID: 3964808 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of intravenous and oral betaxolol on antegrade and retrograde conduction in patients with atrioventricular nodal reentrant and atrioventricular reentrant tachycardia. Kühlkamp V; Ickrath O; Haasis R; Seipel L Eur Heart J; 1989 Jun; 10(6):493-501. PubMed ID: 2569398 [TBL] [Abstract][Full Text] [Related]
11. Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia. Sakurai M; Yasuda H; Kato N; Nomura A; Fujita M; Nishino T; Fujita K; Koike Y; Saito H Am Heart J; 1983 Apr; 105(4):619-28. PubMed ID: 6837416 [TBL] [Abstract][Full Text] [Related]
12. Selective blockade of retrograde fast pathway by intravenous disopyramide in paroxysmal supraventricular tachycardia mediated by dual atrioventricular nodal pathways. Sethi KK; Jaishankar S; Khalilullah M; Gupta MP Br Heart J; 1983 Jun; 49(6):532-43. PubMed ID: 6849716 [TBL] [Abstract][Full Text] [Related]
13. Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia. Wellens HJ; Tan SL; Bär FW; Düren DR; Lie KI; Dohmen HM Br Heart J; 1977 Oct; 39(10):1058-66. PubMed ID: 911555 [TBL] [Abstract][Full Text] [Related]
14. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration]. Kühlkamp V; Ickrath O; Haasis R; Seipel L Z Kardiol; 1988 Aug; 77(8):527-33. PubMed ID: 3176596 [TBL] [Abstract][Full Text] [Related]
15. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia. Musto B; D'Onofrio A; Cavallaro C; Musto A Circulation; 1988 Oct; 78(4):863-9. PubMed ID: 3168194 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous anterograde fast-slow atrioventricular nodal pathway conduction after procainamide. Gomes JA; Kang PS; Kelen G; Khan R; El-Sherif N Am J Cardiol; 1980 Oct; 46(4):677-84. PubMed ID: 7416027 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of termination of reentrant atrioventricular nodal paroxysmal supraventricular tachycardia by intravenous verapamil--an intracardiac electrophysiologic study. Shankar SJ; Sethi KK; Khalilullah M Indian Heart J; 1983; 35(1):8-18. PubMed ID: 6852846 [No Abstract] [Full Text] [Related]
18. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia. Hoff PI; Tronstad A; Oie B; Ohm OJ Am J Cardiol; 1988 Sep; 62(9):585-9. PubMed ID: 3137798 [TBL] [Abstract][Full Text] [Related]
19. The prophylaxis of AV nodal re-entry tachycardia. Tonkin AM; Shorne L Clin Exp Pharmacol Physiol Suppl; 1982; 6():135-43. PubMed ID: 6956473 [TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia. Musto B; D'Onofrio A; Cavallaro C; Musto A; Greco R Am J Cardiol; 1988 Aug; 62(4):229-33. PubMed ID: 3135739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]